NCT00458523
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Kent and Canterbury Hospital Canterbury, England, United Kingdom
- Leeds General Infirmary Leeds, England, United Kingdom
Clinical trial condition
Leukemia, Lymphocytic, Chronic, B-Cell
Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.
1,434 public trials
165 recruiting studies
Leukemia, Lymphocytic, Chronic, B-Cell trial results
NCT00086775
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
- Jackson Oncology Associates, PLLC Jackson, Mississippi, United States
- Cancer Institute of New Jersey at Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States
- Western Pennsylvania Cancer Institute Pittsburgh, Pennsylvania, United States
NCT00005590
- Conditions
- Adnexal Diseases, Brain and Central Nervous System Tumors, Breast Cancer, +83 more
- Locations
-
- University of Birmingham Birmingham, England, United Kingdom
NCT00337246
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Birmingham Heartlands Hospital Birmingham, England, United Kingdom
- Blackpool Victoria Hospital Blackpool, England, United Kingdom
- Kent and Canterbury Hospital Canterbury, England, United Kingdom
- St Helier Hospital Carshalton, England, United Kingdom
NCT00006340
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +47 more
- Locations
-
- Methodist Cancer Center at Methodist Hospital Indianapolis, Indiana, United States
- Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Hopital Necker Paris, France
NCT00749502
- Conditions
- Adnexal Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +38 more
- Locations
-
Not specified
Completed
Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
NCT00564512
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Centre Henri Becquerel Rouen, France
Completed
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
NCT00049686
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
- Locations
-
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
NCT00064090
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +33 more
- Locations
-
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
NCT00304005
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
- Locations
-
- M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States